Biocardia Stock Market Value

BCDA -  USA Stock  

USD 1.55  0.14  8.28%

Biocardia's market value is the price at which a share of Biocardia stock trades on a public exchange. It measures the collective expectations of Biocardia investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Biocardia and determine expected loss or profit from investing in Biocardia over a given investment horizon. Continue to Biocardia Hype Analysis, Biocardia Correlation, Biocardia Valuation, Biocardia Volatility, as well as analyze Biocardia Alpha and Beta and Biocardia Performance.
Symbol
Backtest


Is Biocardia's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocardia. If investors know Biocardia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biocardia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biocardia is measured differently than its book value, which is the value of Biocardia that is recorded on the company's balance sheet. Investors also form their own opinion of Biocardia's value that differs from its market value or its book value, called intrinsic value, which is Biocardia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biocardia's market value can be influenced by many factors that don't directly affect Biocardia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biocardia's value and its price as these two are different measures arrived at by different means. Investors typically determine Biocardia value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biocardia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biocardia 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biocardia's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biocardia.
0.00
03/25/2022
No Change 0.00  0.0 
In 2 months and 2 days
05/24/2022
0.00
If you would invest  0.00  in Biocardia on March 25, 2022 and sell it all today you would earn a total of 0.00 from holding Biocardia or generate 0.0% return on investment in Biocardia over 60 days. Biocardia is related to or competes with Brickell Biotech, and Berkeley Lights. BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for car...

Biocardia Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biocardia's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biocardia upside and downside potential and time the market with a certain degree of confidence.

Biocardia Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biocardia's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biocardia's standard deviation. In reality, there are many statistical measures that can use Biocardia historical prices to predict the future Biocardia's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Biocardia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Biocardia in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.071.497.01
Details
Intrinsic
Valuation
LowReal ValueHigh
0.193.749.26
Details
Naive
Forecast
LowNext ValueHigh
0.0344411.727.24
Details
3 Analysts
Consensus
LowTarget PriceHigh
7.0010.3315.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Biocardia. Your research has to be compared to or analyzed against Biocardia's peers to derive any actionable benefits. When done correctly, Biocardia's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Biocardia.

Biocardia Backtested Returns

Biocardia secures Sharpe Ratio (or Efficiency) of -0.055, which signifies that the company had -0.055% of return per unit of risk over the last 3 months. Macroaxis standpoint towards foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Biocardia exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Biocardia risk adjusted performance of (0.044624), and Mean Deviation of 4.27 to double-check the risk estimate we provide.
The firm shows a Beta (market volatility) of 1.5101, which signifies a somewhat significant risk relative to the market. Let's try to break down what Biocardia's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biocardia will likely underperform. Even though it is essential to pay attention to Biocardia historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Biocardia exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Biocardia has an expected return of -0.31%. Please be advised to confirm Biocardia maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside to decide if Biocardia performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.18  

Very weak predictability

Biocardia has very weak predictability. Overlapping area represents the amount of predictability between Biocardia time series from 25th of March 2022 to 24th of April 2022 and 24th of April 2022 to 24th of May 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biocardia price movement. The serial correlation of 0.18 indicates that over 18.0% of current Biocardia price fluctuation can be explain by its past prices.
Correlation Coefficient0.18
Spearman Rank Test0.42
Residual Average0.0
Price Variance0.02

Biocardia lagged returns against current returns

Autocorrelation, which is Biocardia stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biocardia's stock expected returns. We can calculate the autocorrelation of Biocardia returns to help us make a trade decision. For example, suppose you find that Biocardia stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 
Share
      Timeline 

Biocardia regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biocardia stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biocardia stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biocardia stock over time.
 Current vs Lagged Prices 
Share
      Timeline 

Biocardia Lagged Returns

When evaluating Biocardia's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biocardia stock have on its future price. Biocardia autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biocardia autocorrelation shows the relationship between Biocardia stock current value and its past values and can show if there is a momentum factor associated with investing in Biocardia.
 Regressed Prices 
Share
      Timeline 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Biocardia without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module

Pair Trading with Biocardia

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biocardia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocardia will appreciate offsetting losses from the drop in the long position's value.

Biocardia Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Biocardia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biocardia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biocardia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biocardia to buy it.
The correlation of Biocardia is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biocardia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biocardia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biocardia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Biocardia Hype Analysis, Biocardia Correlation, Biocardia Valuation, Biocardia Volatility, as well as analyze Biocardia Alpha and Beta and Biocardia Performance. Note that the Biocardia information on this page should be used as a complementary analysis to other Biocardia's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Biocardia Stock analysis

When running Biocardia price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Biocardia technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biocardia technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biocardia trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...